PURA Anticipates Continued Sales Growth Multiples In 2020 As CBD Business Expands
April 21 2020 - 11:49AM
InvestorsHub NewsWire
Dallas, TX -- April 21, 2020 -- InvestorsHub
NewsWire -- Puration, Inc. (USOTC:
PURA) today continued with its current program to provide
frequent business updates through the current economic conditions
to keep all apprised of the company’s progress in sustaining its
high growth objectives.
PURA
annual sales since 2016 have multiplied by whole numbers growing
from $100,000 to over $1,000,000. PURA financial reports for
the first three quarters of 2019 demonstrate continued rapid sales
growth already reaching $1,895,000.
The company filed to
extend the reporting period for its 2019 annual report in
conjunction with the current extension parameters and plans to
publish its financial report before the deadline for the current
extension parameters.
Management plans for
PURA over the next few years include the objective of increasing
annual sales by whole number multiples annually. Accordingly,
management is committed to multiple growth in 2020 and believes
current progress has the company on
track.
In addition to the
continued sales expansion of its EVERx CBD Sports Water, the
company has recently initiated an acquisition campaign anticipated
to further contribute to aggressive sales expansion in 2020 and
beyond. PURA has already made two CBD business acquisitions
this year and recently announced entering into due diligence
engagements on three more target
acquisitions.
PURA is
publishing weekly Coronavirus market update reports on the
company’s website. This week’s
update was published yesterday on the annual 420 celebration and in
conjunction with the federal government and state governments
beginning to make plans for reopening the economy. PURA was
fortunate enough to execute a production run of its primary revenue
generator, EVERx CBD Sports Water, just prior to the shutdown and
now, with light at the end of the tunnel, it appears PURA will make
it through to the reopening of the economy with its current
inventory.
Management continues
to carefully move forward and not underestimate the potential of
the Coronavirus economic slowdown presently or even after the
reopening of the economy.
For
more information on Puration, visit http://www.purationinc.com
Disclaimer/Safe Harbor:
This
news release contains forward-looking statements within the meaning
of the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Mar 2023 to Mar 2024
Real-Time news about Puration Inc (CE) (OTCMarkets): 0 recent articles
More Puration Inc (PK) News Articles